Oracle Q3 Cloud Revenue Surges 23%
Database software and cloud services specialist Oracle ( ORCL -4.11%) reported fiscal 2025 third-quarter financial results on Monday, March 10, that fell short of analysts' consensus expectations. With an adjusted EPS of $1.47 and revenue of $14.13 billion, both figures were slightly below estimates of $1.49 and $14.38 billion, respectively.
Oracle Q3 2025 Earnings: CEO Catz Calls AI A ‘Motivator’ For Cloud Adoption
Oracle executives Larry Ellison and Safra Catz talked cloud, AI agents, databases and more on Q3 2025 earnings call.
Oracle Corporation (ORCL) Q3 2025 Earnings Call Transcript
Oracle Corporation ( NYSE: ORCL) Q3 2025 Earnings Conference Call March 10, 2025 5:00 PM ET Ken Bond - Head, IR Safra Catz - CEO Lawrence Ellison - Chairman and CTO
Oracle (ORCL) Q3 2025 Earnings Call Transcript
My name is Abby, and I will be your conference operator today. At this time, I would like to welcome everyone to the Oracle Corporation third quarter fiscal year '25 earnings conference call. All lines have been placed on mute to prevent any background noise.
Oracle Quarterly Revenue Rises, Sees Further Growth Ahead
The cloud-software provider’s results missed Wall Street’s expectations, but shares rose in after-hours trading as the company expects further growth ahead.
Oracle expects 15% revenue growth next fiscal year on strong AI cloud demand
Oracle CEO Safra Catz said that the company's large sales backlog will help drive 15% growth in its revenue next fiscal year, surpassing analysts' current estimates as it expands its artificial intelligence cloud services.
JF Technology acquires 80% stake in Q3
JF Technology Bhd, via wholly-owned subsidiary JF International Sdn Bhd, is acquiring an 80% stake in Q3 Probe Pte Ltd (Q3) ...
Credo Technology Q3: Don't Blame Its Hyperscaler Concentration, Embrace It
Credo Technology reported strong Q3 earnings, beating expectations and raising Q4 revenue guidance. Read why I maintain my ...
What is HC Wainwright’s Forecast for AVDL Q3 Earnings?
Investment analysts at HC Wainwright issued their Q3 2025 earnings estimates for shares of Avadel Pharmaceuticals in a ...